Trial Profile
Study on the Efficacy and Safety of a Therapeutic Strategy of PPH Comparing Early Administration of Human Fibrinogen vs Placebo in Patients Treated With IV Prostaglandins Following Vaginal Delivery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fibrinogen (Primary)
- Indications Postpartum haemorrhage
- Focus Therapeutic Use
- Acronyms FIDEL
- Sponsors LFB
- 30 Nov 2018 Status changed from active, no longer recruiting to completed.
- 15 Sep 2018 This trial has been completed in Belgium (end date: 2018-08-06)
- 09 Jul 2018 Planned End Date changed from 1 Jun 2018 to 1 Sep 2018.